Can effects of antidepressants in patients with mild depression be considered as clinically significant?

Journal of Affective Disorders

Volumn 138, Issue 3, 2012, Pages 183-191

  Hegerl, Ulrich ^a   Allgaier, Antje Kathrin ^b   Henkel, Verena ^b   Mergl, Roland ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antidepressants; Clinical trial; Depression; Hamilton Depression Rating Scale; Placebo verum difference

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; PLACEBO; SERTRALINE; VENLAFAXINE;

COGNITIVE THERAPY; DEPRESSION; HUMAN; PLACEBO EFFECT; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW;

ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84858288130     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.05.015     Document Type: Review

References (71)

1. A.C. Akerblad, F. Bengtsson, L. Ekselius, and L. von Knorring Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners Int. Clin. Psychopharmacol. 18 2003 347 354 (Pubitemid 38183488)
2. J. Angst, and K. Merikangas The depressive spectrum: diagnostic classification and course J. Affect. Disord. 45 1997 31 39 discussion 39-40
3. J. Angst, A. Delini-Stula, M. Stabl, and H.H. Stassen Is a cut-off score a suitable measure of treatment outcome in short-term trials in depression? A methodological meta-analysis Hum. Psychopharmacol. 8 1993 311 317 (Pubitemid 24038673)
4. APA Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association Am. J. Psychiatry 157 2000 1 45
5. APA Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision) 2000 American Psychiatric Publication Inc. Washington DC
6. M. Bauer, T. Bschor, A. Pfennig, P.C. Whybrow, J. Angst, M. Versiani, and H.-J. Möller World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders in primary care World J. Biol. Psychiatry 8 2007 67 104 (Pubitemid 46690921)
7. P. Bech Rating scales in depression: limitations and pitfalls Dialogues Clin. Neurosci. 8 2006 207 215 (Pubitemid 44113991)
8. A.T. Beck Depression: Clinical, Experimental, and Theoretical Aspects 1967 University of Pennsylvania Press Philadelphia, Pennsylvania
9. P. Blier, M.B. Keller, M.H. Pollack, M.E. Thase, J.M. Zajecka, and D.L. Dunner Preventing recurrent depression: long-term treatment for major depressive disorder J. Clin. Psychiatry 68 2007 e06
10. P. Cuijpers, and F. Smit Excess mortality in depression: a meta-analysis of community studies J. Affect. Disord. 72 2002 227 236 (Pubitemid 35351282)
11. P. Cuijpers, F. Smit, J. Oostenbrink, R. de Graaf, M. Ten Have, and A. Beekman Economic costs of minor depression: a population-based study Acta Psychiatr. Scand. 115 2007 229 236
12. P. Cuijpers, A. van Straten, E. Bohlmeijer, S.D. Hollon, and G. Andersson The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size Psychol. Med. 40 2010 211 223
13. J.R. Davidson Major depressive disorder treatment guidelines in America and Europe J. Clin. Psychiatry 71 Suppl. E1 2010 e04
14. S.M. de Maat, J. Dekker, R.A. Schoevers, and F. de Jonghe Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis Eur. Psychiatry 22 2007 1 8 (Pubitemid 46162182)
15. K. Demyttenaere, A. Adelin, M. Patrick, D. Walthere, B. Katrien de, and S. Michele Six-month compliance with antidepressant medication in the treatment of major depressive disorder Int. Clin. Psychopharmacol. 23 2008 36 42 (Pubitemid 350294868)
16. DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, and DGRW S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression - Langfassung 2009 DGPPN, ÄZQ, AWMF Berlin, Düsseldorf
17. D. Faries, J. Herrera, J. Rayamajhi, D. DeBrota, M. Demitrack, and W.Z. Potter The responsiveness of the Hamilton Depression Rating Scale J. Psychiatr. Res. 34 2000 3 10 (Pubitemid 30006935)
18. D.M. Fergusson, L.J. Horwood, E.M. Ridder, and A.L. Beautrais Subthreshold depression in adolescence and mental health outcomes in adulthood Arch. Gen. Psychiatry 62 2005 66 72 (Pubitemid 40096072)
19. J. Fogel, W.W. Eaton, and D.E. Ford Minor depression as a predictor of the first onset of major depressive disorder over a 15-year follow-up Acta Psychiatr. Scand. 113 2006 36 43 (Pubitemid 43339087)
20. K.N. Fountoulakis, and H.-J. Möller Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data Int. J. Neuropsychopharmacol. 2010 1 8
21. J.C. Fournier, R.J. DeRubeis, S.D. Hollon, S. Dimidjian, J.D. Amsterdam, R.C. Shelton, and J. Fawcett Antidepressant drug effects and depression severity: a patient-level meta-analysis JAMA 303 2010 47 53
22. E. Frank, D.J. Kupfer, J.M. Perel, C. Cornes, D.B. Jarrett, A.G. Mallinger, M.E. Thase, A.B. McEachran, and V.J. Grochocinski Three-year outcomes for maintenance therapies in recurrent depression Arch. Gen. Psychiatry 47 1990 1093 1099
23. J.R. Geddes, S.M. Carney, C. Davies, T.A. Furukawa, D.J. Kupfer, E. Frank, and G.M. Goodwin Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review Lancet 361 2003 653 661 (Pubitemid 36246547)
24. J. Geddes, N. Freemantle, J. Mason, M. Eccles, and J. Boynton Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression Cochrane Database Syst. Rev. 3 2006 CD001851
25. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
26. U. Hegerl, and R. Mergl The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences J. Psychopharmacol. 24 2010 445 448
27. U. Hegerl, M. Hautzinger, R. Mergl, R. Kohnen, M. Schütze, W. Scheunemann, A.-K. Allgaier, J. Coyne, and V. Henkel Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm Int. J. Neuropsychopharmacol. 13 2010 31 44
28. V. Henkel, F. Seemüller, M. Obermeier, M. Adli, M. Bauer, C. Mundt, P. Brieger, G. Laux, W. Bender, I. Heuser, J. Zeiler, W. Gaebel, A. Mayr, H.-J. Möller, and M. Riedel Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression J. Affect. Disord. 115 2009 439 449
29. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Harmonised Tripartite Guideline for Good Clinical Practice: With EC Directive (ICH step 4 guidelines) 2001 Brookwood Medical Publications Richmond on Thames
30. L.L. Judd, H.S. Akiskal, J.D. Maser, P.J. Zeller, J. Endicott, W. Coryell, M.P. Paulus, J.L. Kunovac, A.C. Leon, T.I. Mueller, J.A. Rice, and M.B. Keller A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders Arch. Gen. Psychiatry 55 1998 694 700 (Pubitemid 28364385)
31. D.E. Kemp, J.R. Calabrese, J.M. Eudicone, S. Ganocy, Q.V. Tran, R.D. McQuade, R.N. Marcus, E. Vester-Blokland, R. Owen, and B.X. Carlson Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies Psychopharmacol. Bull. 43 2010 5 27
32. I. Kirsch, B.J. Deacon, T.B. Huedo-Medina, A. Scoboria, T.J. Moore, and B.T. Johnson Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration PLoS Med. 5 2008 e45
33. M.S. Klinkman, J.C. Coyne, S. Gallo, and T.L. Schwenk Can case-finding instruments be used to improve physician detection of depression in primary care? Arch. Fam. Med. 6 1997 567 573 (Pubitemid 127439289)
34. S.G. Kornstein Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study Expert. Rev. Neurother. 8 2008 737 742 (Pubitemid 351656824)
35. A.Y. Kuk, J. Li, and A.J. Rush Recursive subsetting to identify patients in the STAR*D: a method to enhance the accuracy of early prediction of treatment outcome and to inform personalized care J. Clin. Psychiatry 71 2010 1502 1508
36. J.M. Lyness, M. Heo, C.J. Datto, T.R. Ten Have, I.R. Katz, R. Drayer, C.F. Reynolds III, G.S. Alexopoulos, and M.L. Bruce Outcomes of minor and subsyndromal depression among elderly patients in primary care settings Ann. Intern. Med. 144 2006 496 504 (Pubitemid 46780672)
37. R. Mergl, V. Henkel, A.-K. Allgaier, D. Kramer, M. Hautzinger, R. Kohnen, J.C. Coyne, and U. Hegerl Are treatment preferences relevant for response to serotonergic antidepressants and cognitive-behavioural therapy in depressed primary care patients? Results from a randomized controlled trial including a patients' choice arm Psychother. Psychosom. 80 2011 39 47
38. H. Middleton, I. Shaw, S. Hull, and G. Feder NICE guidelines for the management of depression BMJ 330 2005 267 268 (Pubitemid 40203636)
39. H.-J. Möller Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008 Eur. Arch. Psychiatry Clin. Neurosci. 258 2008 451 455
40. S.A. Montgomery, J.G. Rasmussen, and P. Tanghøj A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression Int. Clin. Psychopharmacol. 8 1993 181 188 (Pubitemid 23294925)
41. Z. Mosenifar Population issues in clinical trials Proc. Am. Thorac. Soc. 4 2007 185 187 discussion 187-188 (Pubitemid 46743316)
42. NICE Depression: management of depression in primary and secondary care Clinical Practice Guideline No 23 2004 National Institute for Clinical Excellence London
43. NICE Depression: the treatment and management of depression in adults National Clinical Practice Guideline 90 2009 National Institute for Health and Clinical Excellence London
44. A.A. Nierenberg, M.H. Rapaport, P.J. Schettler, R.H. Howland, J.A. Smith, D. Edwards, T. Schneider, and D. Mischoulon Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V CNS Neurosci. Ther. 16 2010 208 216
45. D.J. Nutt, and M. Sharpe Uncritical positive regard? Issues in the efficacy and safety of psychotherapy J. Psychopharmacol. 22 2008 3 6
46. C. Pace, F.G. Miller, and M. Danis Enrolling the uninsured in clinical trials: an ethical perspective Crit. Care Med. 31 2003 S121 S125
47. S. Pampallona, P. Bollini, G. Tibaldi, B. Kupelnick, and C. Munizza Patient adherence in the treatment of depression Br. J. Psychiatry 180 2002 104 109 (Pubitemid 34142778)
48. G.I. Papakostas, R.H. Perlis, M.J. Scalia, T.J. Petersen, and M. Fava A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder J. Clin. Psychopharmacol. 26 2006 56 60 (Pubitemid 43167092)
49. R. Porter, C. Frampton, P.R. Joyce, and R.T. Mulder Randomized controlled trials in psychiatry. Part 1: methodology and critical evaluation Aust. N. Z. J. Psychiatry 37 2003 257 264 (Pubitemid 36833754)
50. M.H. Rapaport, and L.L. Judd Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment J. Affect. Disord. 48 1998 227 232 (Pubitemid 28244225)
51. C.F. Reynolds III, M.A. Dew, B.G. Pollock, B.H. Mulsant, E. Frank, M.D. Miller, P.R. Houck, S. Mazumdar, M.A. Butters, J.A. Stack, M.A. Schlernitzauer, E.M. Whyte, A. Gildengers, J. Karp, E. Lenze, K. Szanto, S. Bensasi, and D.J. Kupfer Maintenance treatment of major depression in old age N. Engl. J. Med. 354 2006 1130 1138
52. W. Rief, Y. Nestoriuc, S. Weiss, E. Welzel, A.J. Barsky, and S.G. Hofmann Meta-analysis of the placebo response in antidepressant trials J. Affect. Disord. 118 2009 1 8
53. L.A. Robinson, J.S. Berman, and R.A. Neimeyer Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research Psychol. Bull. 108 1990 30 49
54. A.J. Rush, S.R. Wisniewski, D. Warden, J.F. Luther, L.L. Davis, M. Fava, A.A. Nierenberg, and M.H. Trivedi Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features Arch. Gen. Psychiatry 65 2008 870 880
55. R.C. Shelton, A. Prakash, C.H. Mallinckrodt, M.M. Wohlreich, J. Raskin, M.J. Robinson, and M.J. Detke Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression Int. J. Clin. Pract. 61 2007 1337 1348 (Pubitemid 47052368)
56. S. Silberman Placebos are getting more effective. Drugmakers are desperate to know why. Wired Magazine (08.24.09) http://www.wired.com/medtech/ drugs/magazine/17-09/ff-placebo-effect?currentPage=all 2009
57. M. Sinyor, A.J. Levitt, A.H. Cheung, A. Schaffer, A. Kiss, Y. Dowlati, and K.L. Lanctot Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses J. Clin. Psychiatry 71 2010 270 279
58. J.R. Sneed, B.R. Rutherford, D. Rindskopf, D.T. Lane, H.A. Sackeim, and S.P. Roose Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression Am. J. Geriatr. Psychiatry 16 2008 65 73
59. H.H. Stassen, J. Angst, D. Hell, C. Scharfetter, and A. Szegedi Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients J. Clin. Psychiatry 68 2007 1195 1205 (Pubitemid 47395621)
60. P. Stolk, M.J. Ten Berg, M.E. Hemels, and T.R. Einarson Meta-analysis of placebo rates in major depressive disorder trials Ann. Pharmacother. 37 2003 1891 1899 (Pubitemid 37466590)
61. A. Szegedi, M.J. Müller, I. Anghelescu, C. Klawe, R. Kohnen, and O. Benkert Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression J. Clin. Psychiatry 64 2003 413 420 (Pubitemid 36547285)
62. A. Tadiç, I. Helmreich, R. Mergl, M. Hautzinger, R. Kohnen, V. Henkel, and U. Hegerl Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression J. Affect. Disord. 120 2010 86 93
63. Task Force for the APA Handbook of Psychiatric Measures Handbook of Psychiatric Measures 2000 APA Washington DC
64. M.J. Taylor, N. Freemantle, J.R. Geddes, and Z. Bhagwagar Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis Arch. Gen. Psychiatry 63 2006 1217 1223 (Pubitemid 44708080)
65. J.W.R. Twisk Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide 2003 Cambridge University Press New York
66. D. van Calker, I. Zobel, P. Dykierek, C.M. Deimel, S. Kech, K. Lieb, M. Berger, and E. Schramm Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy J. Affect. Disord. 114 2009 243 253
67. H.G. Van Spall, A. Toren, A. Kiss, and R.A. Fowler Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review JAMA 297 2007 1233 1240 (Pubitemid 46465731)
68. S. Ventegodt, N.J. Andersen, B. Brom, J. Merrick, and D.E. Greydanus Evidence-based medicine: four fundamental problems with the randomized clinical trial (RCT) used to document chemical medicine Int. J. Adolesc. Med. Health 21 2009 485 496
69. M. Vuorilehto, T. Melartin, and E. Isometsa Depressive disorders in primary care: recurrent, chronic, and co-morbid Psychol. Med. 35 2005 673 682 (Pubitemid 40716431)
70. B.T. Walsh, S.N. Seidman, R. Sysko, and M. Gould Placebo response in studies of major depression: variable, substantial, and growing JAMA 287 2002 1840 1847 (Pubitemid 34303629)
71. WHO The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines 1992 World Health Organization Geneva